New mRNA Cancer Vaccine Passes Important Human Trial

. It involved 157 patients with advanced melanoma who had their tumors completely surgically removed. These patients were randomly split into two groups who received treatment for about a year. One group was given regular infusions of Merck’s Keytruda, a lab-made antibody that helps immune cells better recognize and kill certain cancers. The other group was given Keytruda and nine doses in total of the vaccine candidate, called mRNA-4157/V940.

cancer returning on average than those who only received Keytruda . The vaccine in conjunction with Keytruda also appeared to reduce the combined risk of cancer recurrence and death by 44%.“Today’s results are highly encouraging for the field of cancer treatment.

We all need privacy, especially online. Your IP address and your browsing should be hidden from unecessary surveillance. Rest assured that PIA’s virtual private network never keeps any usage logs—ever.

Awesome news... But here comes the tinfoil hat-wearing bunker crew...

What’s the yellow check mark by your name?

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna's mRNA Skin Cancer Vaccine Shows Early Promise in a New StudyThe company reported encouraging results from a small study define success Success?!?! Are you nuts?! 'Success of its mRNA vaccine' The media party IS the enemy of the people.
Source: TIMEHealth - 🏆 121. / 63 Read more »

Merck, Moderna share positive progress of potential skin cancer vaccineA potential skin cancer vaccine being developed using the same technology behind COVID shots fared well in a small study, the drug companies said. MRNA? Then obviously hell no. Who knows where those skin cancer proteins are headed. No thanks. Yeah, I’ll use sunscreen and get yearly skin checks. Btw, I’m a skin cancer survivor!
Source: FOX29philly - 🏆 570. / 51 Read more »